During epithelial-mesenchymal transition (EMT), a process central to cancer metastasis, tumor cells frequently downregulate or lose EpCAM expression, further reducing the method’s effectiveness in identifying specific CTC subsets (42). This evidence concerns the gene EPCAM and neoplasm.